TRITON MINERALS LTD — Director's Dealing 2014

Sep 1, 2014

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity TRITON MINERALS LIMITED ABN 99 126 042 215

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Alan Gordon JENKS
Date of last notice	22 May 2014

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect/Direct Interest
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Citicorp Nominees Pty Ltd
Date of change	01 September 2014
No. of securities held prior to change Citicorp Nominees Pty Ltd Mr Alan Gordon Jenks	25,840,072 Ordinary fully paid shares; 8,985,000 Ordinary fully paid shares 2,442,500 Unlisted ordinary options, Exercise price $0.10, Expiry Date 31 December 2016
Class	a) Ordinary fully paid shares b) Performance rights
Number acquired	a) 1,000,000 ordinary fully paid shares b) 3,000,000 performance rights
Number disposed	Nil

• See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	a) Nil consideration, value of grant $365,000 b) Nil consideration, value of grant $821,250
No. of securities held after change Citicorp Nominees Pty Ltd Mr Alan Gordon Jenks	25,840,072 Ordinary fully paid shares 9,985,000 Ordinary fully paid shares 2,442,500 Unlisted ordinary options, Exercise price $0.10, Expiry Date 31 December 2016 3,000,000 performance rights expiry 20 August 2018, conversion subject to milestones
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	a) Ordinary fully paid shares issued to directors as remuneration and approved by shareholders at the general meeting held 20 August 2014 b)Performance rights issued in accordance with the Company’s Performance Rights Plan approved by shareholders at the general meeting held 20 August 2014

Part 2 – Change of director’s interests in contracts

Part 2 – Change of director’s interests in contracts	Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in thispart.
Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

Dated: 01 September 2014

• See chapter 19 for defined terms.

Appendix 3Y Page 3

11/3/2002